Wolverine Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-711
Closed -$110K 2439
2021
Q1
$110K Buy
+711
New +$110K ﹤0.01% 1417
2020
Q4
Sell
-913
Closed -$120K 1905
2020
Q3
$120K Buy
+913
New +$119K ﹤0.01% 1104
2020
Q2
Sell
-1,896
Closed -$186K 1806
2020
Q1
$186K Buy
+1,896
New +$249K ﹤0.01% 913
2019
Q3
Sell
-1,706
Closed -$194K 1659
2019
Q2
$194K Buy
+1,706
New +$200K ﹤0.01% 1042
2014
Q4
Sell
-721
Closed -$70K 2539
2014
Q3
$70K Buy
+721
New +$70.9K ﹤0.01% 1430
2014
Q1
Sell
-2,162
Closed -$195K 2816
2013
Q4
$195K Buy
2,162
+515
+31% +$44.6K ﹤0.01% 1163
2013
Q3
$131K Sell
1,647
-206
-11% -$16.2K ﹤0.01% 1347
2013
Q2
$134K Buy
+1,853
New +$139K ﹤0.01% 1295

Other funds holding ZBH

Wolverine Asset Management's ZBH Position: Q2 2021 in Review

Wolverine Asset Management sold out of Zimmer Biomet (ZBH) in Q2 2021, closing a stake of 711 shares — an estimated $110K sold.

Wolverine Asset Management first reported a position in ZBH in Q2 2013 and held it in 8 quarters. The position peaked at $195K in Q4 2013. 1,018 funds tracked by Wall St. Rank hold ZBH as of Q2 2021.

  • Wolverine Asset Management reported no remaining Zimmer Biomet position as of Q2 2021 after selling out during the quarter.
  • Wolverine Asset Management sold 711 Zimmer Biomet shares in Q2 2021, an estimated $110K.
  • Wolverine Asset Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 8 quarters.
  • Wolverine Asset Management's Zimmer Biomet position peaked at $195K in Q4 2013.
  • 1,018 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2021.

Based on Wolverine Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.